The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler, a specialty pharmaceutical product. The $2,099.79 contract has a completion date of February 14, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of the company's...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG inhalers. The $3,729.54 contract has an ultimate completion date of April 8, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) awarded a $7,194.78 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 MCG inhaler 12GM. The contract has a completion date of February 26, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler 12 gm. The $2,760.48 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2025 to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Advair HFA 230-21 MCG Inhaler 12GM pharmaceuticals. The $2,039.46 contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, is the prime contractor for this order, which is not associated with any set-aside program. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM medication. The $3,975.72 contract has a performance period through March 26, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is placed against a $999,999,999.00 indefinite delivery contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 45-21 MCG Inhaler 12GM. The $1,475.93 order has a completion date of February 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. The order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,042.55 for the supply of Advair HFA 230-21 mcg inhalers. The contract has a period of performance through March 1, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a potential value of $1,356.29 and a performance period ending on January 31, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order contract is...